This live educational case from St. Francis Hospital and Heart Center demonstrates imaging-guided intravascular lithotripsy for calcified lesions. It covers lesion selection criteria, preparation and delivery of lithotripsy catheters, and reviews recent clinical evidence to guide best practices.

LIVE Educational Case from St. Francis Hospital & Heart...

• Multi-modality simulation to unveil the hidden parts & small obstacles that can result in complications
• Angioscopy directly inside the coronary artery to provide a better understanding of 3D stent configuration

Commented by Goran Stankovic and William Wijns

Part 1 of a 3-part series.
Next episode: How to correct incomplete crush and...

• Differentiating between complete and incomplete crush
• The importance of sequential crush and bigger balloons, adequately sized according to proximal vessel diameter

Commented by Goran Stankovic and William Wijns

Part 2 of a 3-part series:  
Previous episode: DK Crush like you’ve never seen it before
Coming up next: Main vessel stenting in DK-Crush, lessons...

• Optimisation of side branch stenting
• How to optimally deploy the second stent

Commented by Goran Stankovic and William Wijns

Part 3 of a 3-part series. Previous episode: How to correct incomplete crush and how to prevent lack of carina coverage

A 53‑year‑old man with hypertension and dyslipidemia presented with an inferior MI treated with primary PCI of the RCA two months earlier. He was referred for staged treatment of a significant calcified LAD–diagonal bifurcation lesion. Lesion preparation included non‑compliant balloon dilatation, rotational atherectomy in the LAD...

Nicola Ryan provides her take on the WARRIOR trial which was presented by Eileen Handberg at ACC.25 in Chicago.

The manuscript for this trial has not been published and all assumptions are based upon the presentation.

Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.

It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...